Veracyte
VCYT
$20.35
Share price
0.79%
Change (1 day)
-5.44%
Change (1 year)
Categories
Veracyte (VCYT) - Total debt
Total debt on the balance sheet as of December 2023 : $12.63 M
According to Veracyte's latest financial reports the company's total debt is $12.63 M. A company’s total debt is the sum of all current and non-current debts.
Veracyte - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $12.63 M | -14.19% |
| 2022-12-31 | $14.71 M | -21.93% |
| 2021-12-31 | $18.85 M | 53.08% |
| 2020-12-31 | $12.31 M | -9.49% |
| 2019-12-31 | $13.6 M | -46.18% |
| 2018-12-31 | $25.28 M | 0.14% |
| 2017-12-31 | $25.24 M | -1.06% |
| 2016-12-31 | $25.51 M | 411.36% |
| 2015-12-31 | $4.99 M | 1.36% |
| 2014-12-31 | $4.92 M | 0.49% |
| 2013-12-31 | $4.89 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Exact Sciences EXAS | $2.55 B | 20,127.47% | 🇺🇸 USA |
 Myriad Genetics MYGN | $0.15 B | 1,104.28% | 🇺🇸 USA |
 Biocept
BIOC | $11.59 M | -8.23% | 🇺🇸 USA |